BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28279785)

  • 1. Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.
    Younus I; Reddy DS
    Pharmacol Ther; 2017 Sep; 177():108-122. PubMed ID: 28279785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.
    Clossen BL; Reddy DS
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1519-1538. PubMed ID: 28179120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Histone Deacetylation Inhibition Prevents the Development and Persistence of Temporal Lobe Epilepsy.
    Reddy SD; Clossen BL; Reddy DS
    J Pharmacol Exp Ther; 2018 Jan; 364(1):97-109. PubMed ID: 29101217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
    Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
    Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.
    Boison D; Rho JM
    Neuropharmacology; 2020 May; 167():107741. PubMed ID: 31419398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and Epilepsy.
    Henshall DC; Kobow K
    Cold Spring Harb Perspect Med; 2015 Oct; 5(12):. PubMed ID: 26438606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and epilepsy.
    Pulido Fontes L; Quesada Jimenez P; Mendioroz Iriarte M
    Neurologia; 2015 Mar; 30(2):111-8. PubMed ID: 24851699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus.
    Zybura-Broda K; Amborska R; Ambrozek-Latecka M; Wilemska J; Bogusz A; Bucko J; Konopka A; Grajkowska W; Roszkowski M; Marchel A; Rysz A; Koperski L; Wilczynski GM; Kaczmarek L; Rylski M
    PLoS One; 2016; 11(8):e0159745. PubMed ID: 27505431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting epigenetic DNA and histone modifications to treat kidney disease.
    Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
    Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.
    Zeng LH; Rensing NR; Wong M
    Mol Cell Pharmacol; 2009 Jan; 1(3):124-129. PubMed ID: 20419051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of epilepsy target genes contributes to a cellular memory of epileptogenesis in cultured rat hippocampal neurons.
    Kiese K; Jablonski J; Hackenbracht J; Wrosch JK; Groemer TW; Kornhuber J; Blümcke I; Kobow K
    Acta Neuropathol Commun; 2017 Oct; 5(1):79. PubMed ID: 29089052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and noncoding RNA: Recent developments and future therapeutic opportunities.
    Henshall DC
    Eur J Paediatr Neurol; 2020 Jan; 24():30-34. PubMed ID: 31235424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy.
    Chen S; Huang M; Xu D; Li M
    Neurochem Int; 2024 Feb; 173():105657. PubMed ID: 38145842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.
    Löscher W
    Neuropharmacology; 2020 May; 167():107605. PubMed ID: 30980836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
    Wong M
    Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats.
    Citraro R; Leo A; De Caro C; Nesci V; Gallo Cantafio ME; Amodio N; Mattace Raso G; Lama A; Russo R; Calignano A; Tallarico M; Russo E; De Sarro G
    Mol Neurobiol; 2020 Jan; 57(1):408-421. PubMed ID: 31368023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs.
    Navarrete-Modesto V; Orozco-Suárez S; Feria-Romero IA; Rocha L
    Epilepsy Res; 2019 Jan; 149():53-65. PubMed ID: 30476813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in epilepsy.
    Kumar S; Shanker OR; Banerjee J; Tripathi M; Chandra PS; Dixit AB
    Prog Mol Biol Transl Sci; 2023; 198():249-269. PubMed ID: 37225322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epigenetics of Epilepsy and Its Progression.
    Hauser RM; Henshall DC; Lubin FD
    Neuroscientist; 2018 Apr; 24(2):186-200. PubMed ID: 28468530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.